BioCentury | Mar 6, 2017
Clinical News

OMT-28: Ph I started

...evaluate single and multiple ascending doses of oral OMT-28 in up to 100 healthy volunteers. Omeicos Therapeutics GmbH...
...metabolite Indication: Treat atrial fibrillation (AF) Endpoint: Safety; pharmacokinetics Status: Phase I started Milestone: NA Nora Weintraub OMT-28 Omeicos Therapeutics GmbH...
BioCentury | Mar 3, 2017
Financial News

Omeicos completes venture financing

...On March 1, cardiovascular disease company Omeicos Therapeutics GmbH (Berlin, Germany) raised €8.3 million ($8.8 million) in the...
...Gründerfonds, The Falck Revocable Trust, Ascenion and company management also participated. Omeicos Therapeutics GmbH , Berlin, Germany Alex Himes Omeicos Therapeutics GmbH...
BioCentury | May 6, 2015
Company News

Management tracks

...it acquired Calistoga Pharmaceuticals Inc. , where he had been EVP of R&D. Cardiovascular play Omeicos Therapeutics GmbH...
BioCentury | Apr 20, 2015
Financial News

Omeicos Therapeutics completes venture financing

Omeicos Therapeutics GmbH , Berlin, Germany Business: Cardiovascular Date completed: 2015-04-15 Type: Venture financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners; SMS Investments; VC Fonds Berlin; High-Tech Gruenderfonds; KfW WIR Staff Cardiovascular...
Items per page:
1 - 4 of 4
BioCentury | Mar 6, 2017
Clinical News

OMT-28: Ph I started

...evaluate single and multiple ascending doses of oral OMT-28 in up to 100 healthy volunteers. Omeicos Therapeutics GmbH...
...metabolite Indication: Treat atrial fibrillation (AF) Endpoint: Safety; pharmacokinetics Status: Phase I started Milestone: NA Nora Weintraub OMT-28 Omeicos Therapeutics GmbH...
BioCentury | Mar 3, 2017
Financial News

Omeicos completes venture financing

...On March 1, cardiovascular disease company Omeicos Therapeutics GmbH (Berlin, Germany) raised €8.3 million ($8.8 million) in the...
...Gründerfonds, The Falck Revocable Trust, Ascenion and company management also participated. Omeicos Therapeutics GmbH , Berlin, Germany Alex Himes Omeicos Therapeutics GmbH...
BioCentury | May 6, 2015
Company News

Management tracks

...it acquired Calistoga Pharmaceuticals Inc. , where he had been EVP of R&D. Cardiovascular play Omeicos Therapeutics GmbH...
BioCentury | Apr 20, 2015
Financial News

Omeicos Therapeutics completes venture financing

Omeicos Therapeutics GmbH , Berlin, Germany Business: Cardiovascular Date completed: 2015-04-15 Type: Venture financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners; SMS Investments; VC Fonds Berlin; High-Tech Gruenderfonds; KfW WIR Staff Cardiovascular...
Items per page:
1 - 4 of 4